Brief: Recursion Reports Grant Of Inducement Awards As Permitted By The Nasdaq Listing Rules
31/07/2026 22:13
BRIEF-Recursion Reports Grant Of Inducement Awards As Permitted By The Nasdaq Listing Rules July 31 (Reuters) - Recursion Pharmaceuticals Inc RXRX.O:
RECURSION REPORTS GRANT OF INDUCEMENT AWARDS AS PERMITTED BY THE NASDAQ LISTING RULES
Source text: ID:nGNX5BrLK2
Further company coverage: RXRX.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Recursion Pharmaceuticals
See all newsBrief: Tempus And Recursion Extend Existing Data License Agreement And Enter New License Agreement For Recursion’S RNA Foundation Model
Brief: Recursion Pharmaceuticals Enters Amendment To Master Agreement With Tempus On Sept 15, 2026 - SEC Filing
Recursion Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Recursion Pharmaceuticals Q2 revenue misses estimates, cuts 2026 expense outlook
Brief: Recursion Pharmaceuticals Q2 Operating Revenue USD 7.303 Million Vs. IBES Estimate USD 11.9 Million